| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |